Funder
Natural Science Foundation of Inner Mongolia Autonomous Region
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Mallick UK. The Revised American Thyroid Association Management Guidelines 2009 for patients with differentiated thyroid cancer: an evidence based risk adapted approach. Clin Oncol. 2010;22(06):472–4.
2. Véronique Terrasse. Global cancer burden growing, amidst mounting need for services. The International Agency for Research on Cancer (IARC), 1 February 2024, PRESS RELEASE No. 345.
3. Schlumberger M, Tahara M, Wirth LJ, Robinson B, Brose MS, Elisei R, Habra MA, Newbold K, Shah MH, Hoff AO, et al. Lenvatinib versus placebo in radioiodine-refractory Thyroid cancer. N Engl J Med. 2015;372(7):621–30.
4. Yu X, Song X, Sun W, et al. Independent risk factors predicting central lymph node metastasis in papillary Thyroid microcarcinoma. Horm Metab Res. 2017;49(3):201–7.
5. Wang J, Wei W, Guo R. Ultrasonic elastography and conventional ultrasound in the diagnosis of Thyroid micro-nodules. Pak J Med Sci. 2019;35(6):1526.